找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunomodulators and Biologics in Dermatologic Treatment; Turning Theory into Neal Bhatia Book 2024 The Editor(s) (if applicable) and The

[復制鏈接]
樓主: Helmet
21#
發(fā)表于 2025-3-25 05:56:40 | 只看該作者
22#
發(fā)表于 2025-3-25 11:12:07 | 只看該作者
JAK Inhibitors as Immunomodulators, transcription of other effector cytokines. The clinical relevance to dermatologists including the impact on inflammation and pathogenesis of diseases such as atopic dermatitis, psoriasis, vitiligo, and other conditions including clinical trial data, topical and systemic therapies, and future medica
23#
發(fā)表于 2025-3-25 12:26:16 | 只看該作者
24#
發(fā)表于 2025-3-25 18:59:28 | 只看該作者
25#
發(fā)表于 2025-3-25 20:26:20 | 只看該作者
Antibiotics and Antimicrobials as Immunomodulators,kill pathogens or to inhibit their reproduction or growth. However, many of these agents have additional immunomodulatory effects, direct and indirect, due to common pathways and structural similarities between pathogens and humans. Dermatologists are amongst the top prescribers of antimicrobial age
26#
發(fā)表于 2025-3-26 01:55:25 | 只看該作者
Integrative Therapies as Immunomodulators,rings together many facets of immunology and immunomodulation. The diverse origins of therapies, including herbal, botanical, spice roots, and other natural sources, give rise to many applications as anti-inflammatory agents. Dermatologists incorporate integrative therapies in diseases such as acne,
27#
發(fā)表于 2025-3-26 04:19:03 | 只看該作者
28#
發(fā)表于 2025-3-26 10:44:11 | 只看該作者
Immunomodulators for Common Dermatologic Disorders: A Focus on Acne, Rosacea, Seborrheic Dermatitis of inflammation in disease progression. Treatment approaches for these conditions involve targeting various contributing factors, with a focus on combination therapies tailored to disease severity. Recent advancements in microencapsulated formulations and novel agents offer promising avenues for en
29#
發(fā)表于 2025-3-26 12:52:21 | 只看該作者
30#
發(fā)表于 2025-3-26 18:07:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
封开县| 芜湖市| 铜山县| 东阿县| 淮北市| 仁怀市| 聂拉木县| 贵定县| 宁安市| 长垣县| 景宁| 吴忠市| 鞍山市| 安远县| 铜山县| 清河县| 通州市| 霞浦县| 靖宇县| 思茅市| 句容市| 荃湾区| 张家口市| 萨迦县| 新民市| 建水县| 禄劝| 康乐县| 临安市| 镇宁| 阳新县| 富裕县| 乐陵市| 宕昌县| 库伦旗| 宜黄县| 任丘市| 新蔡县| 平顶山市| 英德市| 资阳市|